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Abstract
Background: Cancer-initiating cells (CICs) are proposed to be responsible for the generation of metastasis and
resistance to therapy. Accumulating evidences indicates CICs are found among different human cancers and cell
lines derived from them. Few studies address the characteristics of CICs in cervical cancer. We identify biological
features of CICs from four of the best-know human cell lines from uterine cervix tumors. (HeLa, SiHa, Ca Ski, C-4 I).
Methods: Cells were cultured as spheres under stem-cell conditions. Flow cytometry was used to detect
expression of CD34, CD49f and CD133 antigens and Hoechst 33342 staining to identify side population (SP).
Magnetic and fluorescence-activated cell sorting was applied to enrich and purify populations used to evaluate
tumorigenicity in nude mice. cDNA microarray analysis and in vitro radioresistance assay were carried out under
standard conditions.
Results: CICs, enriched as spheroids, were capable to generate reproducible tumor phenotypes in nu-nu mice and
serial propagation. Injection of 1 × 10
3 dissociated spheroid cells induced tumors in the majority of animals,
whereas injection of 1 × 10
5 monolayer cells remained nontumorigenic. Sphere-derived CICs expressed CD49f
surface marker. Gene profiling analysis of HeLa and SiHa spheroid cells showed up-regulation of CICs markers
characteristic of the female reproductive system. Importantly, epithelial to mesenchymal (EMT) transition-associated
markers were found highly expressed in spheroid cells. More importantly, gene expression analysis indicated that
genes required for radioresistance were also up-regulated, including components of the double-strand break (DSB)
DNA repair machinery and the metabolism of reactive oxygen species (ROS). Dose-dependent radiation assay
indicated indeed that CICs-enriched populations exhibit an increased resistance to ionizing radiation (IR).
Conclusions: We characterized a self-renewing subpopulation of CICs found among four well known human
cancer-derived cell lines (HeLa, SiHa, Ca Ski and C-4 I) and found that they express characteristic markers of stem
cell, EMT and radioresistance. The fact that CICs demonstrated a higher degree of resistance to radiation than
differentiated cells suggests that specific detection and targeting of CICs could be highly valuable for the therapy
of tumors from the uterine cervix.
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On the global scale, cervical cancer represents the sec-
ond most frequent cancer in women with approximately
530,000 new cases registered each year and >274,000
deaths worldwide [1].
Currently, approximately 35% of women diagnosed with
cervical cancer have recurrent disease, with 90% of these
found within 3 years after the initial treatment [2]. Thus,
improved targeted therapies and chemo-radiosensitization
strategies are essential for reducing the mortality of this
devastating malignancy.
One emerging model for the development of drug and
radio-resistant invokes the existence within tumors of a
pool of self-renewing malignant progenitors known as
cancer-initiating cells (CICs ) ,a tt h et o po fah i e r a r c h y
from which cells with distinct degrees of differentiation
derive [3]. If CICs are more resistant to radiation, relapse
after partial remission could likely be due to failure to
eradicate these cells which, despite bulk tumor shrinkage
can subsequently reproduce the entire malignant pheno-
type [4]. Indeed, normal stem cells have been shown to
possess several characteristics that confer chemo- and
radioresistance [4,5].
CICs were first identified in acute myeloid leukemia as
possessing the cell surface antigenic phenotype CD34
+CD38‒ and the capacity to reproduce the complete leu-
kemic hierarchy upon xenoengraftment [6,7]. Similar to
the hematopoietic system, epithelial linings of the
majority of tissue surfaces undergo continuous turnover
and are organized according to a stem cell hierarchy [3].
In 2003, CD24‒CD44
+ cells were isolated from human
breast tumors that could be serially propagated in ani-
mals and could recapitulate their original phenotype [8].
CICs have since been identified from numerous other
epithelial malignancies [9-12]. A consensus of five defin-
ing criteria has been establish e dt oa f f i r mt h ee x i s t e n c e
of CICs: (a) capacity to self-renew; (b) tumorigenic
potential to recreate the full phenotypic heterogeneity of
the parent tumor; (c) expression of distinctive cells mar-
kers; (d) differentiation into nontumorigenic cells, and
(e) restriction to a small minority of the total tumor
population [3,13]. However, concerning this last feature
the use of highly immunocompromised NOD/SCID
interleukin-2 receptor gamma chain null mice, has
shown that the detection of tumorigenic melanoma cells
can be increased by several orders of magnitude [14].
In the case of cervical cancer, Feng et al. [15], isolated 8/
19 tumor-derived cultures encompassing stem-like cells
capable of self-renewal and extensive proliferation as clo-
nal nonadherent spherical clusters. Xenoengraftment of 1
×1 0
5 dissociated spheroid cells allowed full recapitulation
of the original tumor, whereas the same amount of non-
selected tumor cells remained non-tumorigenic remained
non-tumorigenic. Furthermore, Sox2 staining was detected
in the majority of tumor sphere cells isolated from fresh
cervical cancer tissues but not from the differentiated
cells. When Sox2 was stably expressed in cervical cancer
cells (SiHa and HeLa), overexpressing cells had increased
proliferation, clonogenicity, and tumorigenicity in vitro
and in vivo [16].
Established cancer cell lines can be maintained indefi-
nitely in culture and usually can form tumors when trans-
planted in vivo. Cancer cell lines are attractive and
reproducible models for cancer studies and represent an
alternative source for CICs research. However, studies
with well -established cervical cell lines that allow a better
understanding of CICs are still needed. The objective of
this study was to isolate and characterize cervical CICs
(CCICs) from four well-known established cell lines.
These cells are fully capable of self renewing and of serially
propagating tumors in nu-nu mice. CCICs-enriched
spheroids fulfill currently accepted criteria for the exis-
tence of a subpopulation of CICs [3,13]. Gene profiling
analysis showed increased expression of adult CICs mar-
kers, genes involved in DNA double-strand breaks (DSB)
repair and genes involved in an epithelial to mesenchymal
transition. Importantly, sphere-forming CCICs demon-
strated a higher degree of radioresistance than differen-
tiated cells suggesting that specific detection and targeting
of CICs could be highly valuable for the therapy of recur-
rent chemo-radioresistant tumors of the uterine cervix.
Methods
Cell culture
HeLa, SiHa, Ca Ski, and C-4 I human cervical cell lines
were maintained in Dubelcco’s modified Eagle’s medium
(DMEM, Gibco) supplemented with 10% fetal bovine
serum (FBS, Gibco), 100 units/ml penicillin (Gibco) and
100 μg/ml streptomycin (Gibco). In all experiments,
cells were maintained at 37°C, 5% CO2, and 95% air
atmosphere. All of our experiments were performed on
cultures that were 70% confluent.
Culture and passage of tumor spheres
Cells were placed in serum-free medium (SFM) mixed
with 20 ng/ml epidermal growth factor (EGF, Invitrogen),
20 ng/ml basic fibroblast growth factor (bFGF, Invitro-
gen), and 0.4% bovine serum albumin (BSA, Sigma-
Aldrich) at a density of 1 × 10
3 cells/ml and cultured in
ultra low attachment plates (Costar). The sphere culture
media was changed every 48 h until the majority of
spheres reached 100-400 μm in diameter (approximately
7 days). Spheres were collected by gentle centrifugation
(5 min at 2,500 rpm), dissociated with EDTA 1.0 mM,
and mechanically disrupted with a fire-polished Pasteur
pipette. The cell suspension was sieved through a cell
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suspension and then re-plated in complete fresh medium.
Sphere-forming efficiency assay
For analysis of sphere formation, subconfluent cells were
thoroughly dissociated with EDTA to prepare a single-
cell suspension that was always visually verified. Then,
100 cells per well were plated in 96-well culture dishes in
200 μl of growth medium, and 25 μl of medium per well
was added every 2 days. The number of spheres for each
well was evaluated 7 days after seeding and sphere forma-
tion rate was counted. Sphere-forming efficiency (SFE)
was calculated as the number of spheres formed divided
by the original number of single cells seeded and
expressed as a percentage [17]. SFE was calculated from
first through the fifth generation. All experiments were
done in triplicate.
Differentiation assay
To examine cervical tumor-like epithelial differentiation
of anchorage-independent cells, spheres were dissociated
with EDTA and single cells were plated onto glass cover
slips pre-coated with poly-L-lysine (Sigma-Aldrich)
under standard conditions, DMEM/F12 supplemented
with 10% FBS without growth factors. Cells were placed
on cover slips, fed with FBS-supplemented medium every
2 days and processed 7 days after plating. Immunocyto-
chemistry was performed with human anti-cytokeratin
(AE1/3 clone, 1:50 final dilution, Dako) and visualized
with LSAB + System-HRP (Dako). The chromogene was
3,3’-diaminobenzidine tetrahydrochlorate (Dako) solution
developed with H2O2. Sections were counterstained with
hematoxylin, dehydrated and cleared in xylene, and then
mounted with Eukitt medium.
Clonogenic assay
Each well (35-mm) of a six-well culture dish was coated
with 2 ml bottom agar-medium mixture (DMEM, 10%
FBS, 0.6% agar). After solidifying, 2 ml top agar-medium
mixture (DMEM, 10% FBS, 0.3% Noble agar, BD Difco)
containing cells was added, and dishes were incubated
at 37°C for 21 days. Colonies were fixed with 6.0% glu-
taraldehyde, stained with 0.5% crystal violet, and
counted using a dissecting microscope to determinate
plating efficiency (PE).
Surface marker analysis by flow cytometry
One million cells were incubated for 10 min at 4°C with
FcR blocking reagent (Miltenyi Biotech), followed by
labeling with monoclonal antibodies to CD34 (AC136
clone, 1:11 dilution, Miltenyi Biotec), CD49f (GoH3
clone, 1:11 dilution, Becton Dickinson) and CD133
(AC133/1 clone, 1:11 dilution, Miltenyi Biotec). After 15
min at 4°C, cells were extensively washed with ice-cold
PBS and resuspended in 0.5 μg/ml propidium iodide
(PI) for 10 min at room temperature, and shielded from
light prior to flow cytometry analysis with FACSCalibur
(BD Biosciences, CA, USA) and Cell Quest Pro software
( B DB i o s c i e n c e s ,C A ,U S A ) .F l u o r o c h r o m e - c o n j u g a t e d
isotype-matched monoclonal antibodies from the same
manufacturers were utilized to establish background
fluorescence. CD133
+ and CD34
+ hematopoietic stem
cells from umbilical cord blood were obtained from con-
senting mothers after full-term delivery and used as
positive controls for CD133 and CD34 labeling. Human
peripheral blood leukocytes were used as positive con-
trol for CD49f labeling.
Characterization of SP population
One millions of cells were resuspended in 1.0 ml of pre-
warmed DMEM at 37°C containing 2% FBS, 1 mM
Hepes, and 5 μg/ml Hoechst 33342 (Sigma-Aldrich) and
were incubated under constant and slow agitation for 90
mn at 37°C. When Verapamil was used to block
Hoechst efflux, cells were stained as described in the
presence of 50 μM Verapamil (Sigma-Aldrich) [18].
After staining, cells were washed with Hank’s buffered
salt solution, resuspended in ice-cold staining media,
and then maintained on ice until their analysis or sort-
ing. Immediately before analysis, PI was added at a final
concentration of 2 mg/ml. Bone marrow cells were used
as positive control. Murine bone marrow was extracted
from the femurs and tibias of C57B1/6 mice, a single-
cell suspension was made by passage of the bone mar-
row through an 18-gauge needle, and the cells were pel-
leted by centrifugation. Analysis and sorting were
performed with a MoFlo Cell Sorter (Beckman Coulter,
CA, USA) employing 60-mW multiline ultraviolet (UV)
from a coherent I-90 laser. Hoechst blue was detected
at 424/24 nm and Hoechst red at 590/30. The channels
w e r es e p a r a t e db ya5 5 5 L Pd i c hromic beam-splitter.
Sorting was carried out using a 100-lm nozzle and at
35-W sheath pressure, utilizing the purity-1 mode. Dye
effluxing cells appear as a low fluorescing population
termed the side population (SP).
Isolation by magnetic (MCS) and fluorescence cell sorting
(FCS)
Human cervical cells lines were magnetically labeled and
separated by double passage with 1 μl CD133 (CD133/1
clone, Miltenyi Biotec) and 1 μl CD34 microbeads
(QBEND/10 clone, Miltenyi Biotec) per 1 × 10
6 cells,
utilizing the Miltenyi Biotec CD34 and CD133 cell isola-
tion kit. Indirect and positive separation was performed
for CD49f using anti-phicoeritrin (PE) microbeads (PE4-
14D10 clone, MiltenyiBiotec) and anti-CD49f-PE (GoH3
clone, Becton Dickinson). Magnetically enriched popula-
tions and SP were sorted with a MoFlo Cell Sorter
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acquired for each sample and cells positive for PI were
gated out. After separation by MACS and/or FACS, ali-
quots of positive and negative sorted populations were
evaluated for purity by flow cytometry with a FACSCali-
bur (BD Biosciences, CA, USA) and Cell Quest software
(BD Biosciences, CA, USA) using CD133/2-PE (239C3
clone, Miltenyi Biotec), CD49f (450-30A clone, Serotec),
and CD34-PE antibodies (AC136 clone, Miltenyi Biotec).
Purities ranged from 83 to 94% for positive and 89-
99.7% for negative populations.
In vivo xenograft experiments
All animal experiments adhered to the requirements of
NOM-062-ZOO-1999 Mexican Official Law and proto-
cols were approved by the Ethics Committee of the Bio-
medical Research Institute, UNAM. Dissociated cells
obtained under adherent and nonadherent conditions
were counted and resuspended in 100 μlo fF B Sa n d
growth factor-free DMEM at different cell densities.
Cells were injected subcutaneously (s.c.) into the left
and right flanks of 4-6-week-old female nude athymic
mice (BALB/c-nu/nu). Engrafted mice were inspected
weekly for tumor appearance by visual observation and
palpation. Six weeks after transplantation mice were
euthanized and tumor tissue collected. Tumors were
digested usually during 1 h using dispase solution
(1 mg/ml, Invitrogen) and 0.5% collagenase Type I (Invi-
trogen). They were stirred slowly at 37°C until the tissue
was completely dissolved. Dispersed cells were then
separated from residual tissue by passing the mixture
through a 40-μm cell strainer to produce a single-cell
suspension. Cells were obtained by centrifugation and
plated in SFM. After reformation and dissociation of
spheroids, single cells were reinjected into mice and,
similar to the tumor mincing studies, the entire process
was repeated. The remaining tumor, fixed in 10% buf-
fered formalin and embedded in paraffin was sectioned
(5-μm) on a rotary microtome and subsequently stained
with hematoxylin and eosin (H&E) for histological eva-
luation and immunohistochemistry. Immunostaining
was performed using tissue sections mounted on poly-
L-lysine-coated slides and dried at 37°C overnight. The
slides were deparaffinized in xylene and rehydrated.
Endogenous peroxidase was blocked with 3% H2O2 for
5 min. To reduce nonspecific binding, the sections were
incubated with 20% normal goat serum for 30 min at
room temperature. Cells expressing human epithelial
cytokeratins were identified after overnight incubation at
4°C with anti-cytokeratin AE1/3, as described above.
cDNA microarray analysis
Total RNA was extracted utilizing AllPrep DNA/RNA
Micro Kit (Qiagen) and reverse-transcribed with the
MessageAmp™ II aRNA Amplification Kit (Ambion) to
generate Cy3-and Cy5-labeled (Ambion) cDNA probes
for adherent and nonadherent samples, respectively. The
labeled probes were hybridized to a cDNA Stanford
University Microarray containing 40,000 immobilized
oligonucleotide probes. Different fluorescently labeled
cDNA probes were mixed in 45 μl of hybridization buf-
fer DIG Easy Hyb (Roche), applied to the microarray
and incubated at 37°C for 16 h. After hybridization
slides were washed with 0.1 X SSC/0.1% SDS, 0.1 X SSC
and 0.01 X SSC for 5 min at room temperature. Fluores-
cence intensities of Cy3 and Cy5 targets were measured
and scanned separately using the GenePix 4100A Array
Scanner (Axon Instruments, CA, USA). Images and
quantitative data of gene-expression levels were pro-
cessed and analyzed by GenePix Pro V5.0 (Axon Instru-
ments, CA, USA). The array data for expression of
12,500 genes were filtered and genes with a median
expression increased or decreased by a factor of at least
1.5-fold were selected. A total of 638 genes in HeLa and
8 5 7g e n e si nS i H aw e r ec l u s t e r e db yt h eu s eo fW e b -
Gestalt (Gene Set Analysis Toolkit). Two independent
experiments were performed.
Radioresistance assay
Cells from both monolayer cultures and 7-day-old
spheres were enzymatically dissociated with EDTA and
mechanically dissociated with a Pasteur pipette, both
passed through a 40-μm sieve and immediately irra-
diated as single-cell DMEM suspension at a dose rate of
240 cGy/min for the time required to generate dose
curves of 2, 4, 6, 8, and 10Gy with a linear accelerator
Clinac 2100C, (Varian Medical Systems, CA, USA),
operating at 6 MV. Corresponding controls were sham-
irradiated. Colony-forming assays were performed
immediately after irradiation by plating cells into tripli-
cate six-well culture dishes. After 21 days, colonies were
fixed with 6.0% glutaraldehyde, stained with 0.5% crystal
violet, and counted. To generate a radiation survival
curve, the surviving fraction (SF) at each radiation dose
was normalized to that of the sham-irradiated control,
and curves were fitted using a linear-quadratic model,
SF. = exp(-ad-bd
2)i nw h i c ha is the number of logs
of cells killed per gray from the linear portion of the
survival curve, and b is the number of logs of cells killed
per gray
2 from the quadratic component. Three inde-
pendent experiments were performed.
Statistical analysis
The approximation of data distribution to normality was
preliminarily tested. Results are presented as mean and
differences of the means with standard deviations (SDs)
or 95% confidence intervals (CI). Statistical analysis was
performed using factorial design analysis of variance
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as appropriate utilizing Minitab 15™ software. Statistical
significance when p < 0.05.
Results
A subpopulation of cells with self-renewing and sphere-
formation capacity is found among different cell lines
established from tumors of the uterine cervix
Cells from four well-known cell lines derived from either
squamous carcinomas (SiHa, Ca Ski, and C-4 I) or adeno-
carcinomas (HeLa) of the uterine cervix were cultured at
low density (1,000 cells/ml) as suspension in serum-free
sphere medium. Six days after plating, nonadherent sphe-
rical clusters of cells were observable with different mor-
phologic phenotypes (Figure 1a) similar to spheroids
isolated from human primary tumor tissues and cell lines
[15,16,19]. All spheroids increased progressively in dia-
meter (Figure 1b). Sphere formation efficiency (SFE) in the
first generation was 7.8 ± 0.69% (mean ± SD; n = 10 inde-
pendent experiments) for HeLa, 6.8 ± 0.57% for SiHa, 4.7
± 0.34% for Ca Ski, and 4.4 ± 0.54% for C-4 I, respectively
(Figure 1c). After 7 days in culture primary cervospheres
were collected by gentle centrifugation, dissociated, sieved,
and re-plated at low density in order to give rise to sec-
ondary spheres. SFE was found to be higher in the second
generation indicating an increased capacity for sphere for-
mation from passages 1 to 2. Although this enhanced
capacity does not persist for several passages spheres
could be serially passaged for up to 10 generations and
approximately 1-5% of them remained as larger, sym-
metric, prototypical spheroids providing a definitive
evidence for the presence of extended self-renewal. Addi-
tionally, when single cells from spheroids were cultured
during 7 days under standard differentiating conditions,
floating cells could adhere, acquire an epithelial morphol-
ogy, form symmetric colonies, and survive subsequent pas-
sages. As expected, when we examined spheroid-derived
cells for CD49f and CD133 CICs markers under differen-
tiating conditions, expression was lost or greatly reduced
after 7 days to minimal expression values similar to mono-
layer cells. Finally, to further support possible differentia-
tion of cell derived from spheres, expression of epithelial
differentiation markers was examined demonstrating posi-
tivity for cytokeratin AE1/3 in all differentiated spheroids
(data not shown). Taken together these data indicate that
a subpopulation of cells from spheroids self-renew and dif-
ferentiate assuming an epithelial tumor phenotype. In
addition, to determine whether cells from spheroids pos-
sess proliferative potential, we determined their clonogeni-
city in vitro. Cells from spheroids plated at low densities
under anchorage-independent conditions showed signifi-
cantly higher colony-forming abilities compared with their
monolayer counterparts. Cells from HeLa, SiHa, Ca Ski,
and C-4 I spheroids gave rise to a 1.9-, 1.5-, 2.0- and
2.4-fold greater number of colonies than those from
monolayers, respectively. Cells from SiHa spheroids exhib-
ited higher plating efficiency (PE) values (0.95 ± 0.09%)
than Hela (0.8 1 ± 0.06%), C-4 I (0.44 ± 0.08%), and Ca Ski
(0.42 ± 0.07%) (mean ± SD; n = three independent experi-
ments), and these numbers were significantly greater than
those obtained from monoloyer cells (p <0 . 0 5a n dp <
0.01), (Additional file 1: Figure S1, available online). These
results are consistent with the possibility that cervospheres
might be enriched in CCICs.
Sphere-forming cells express CD49f
Previous studies showed expr e s s i o no fC D 3 4a sah e m a -
topoietic stem cells marker [6,7], so tested it as the blood
and urogenital systems share the same embryonic origin.
CD49f has been used as epithelial stem marker in human
epidermis [20,21] CD133 is one of the most widely used
markers to identify CICs, including epithelial tissues [22].
We performed an initial screen with CD44 and CD71
and found preliminary in vivo tumorigenicity assays
showed that these populations were not able to generate
tumors. We determine whether cultured epithelial cells
grown as spheroids are enriched for cells expressing
these stem-cell markers. The vast majority of cells stained
positive for CD49f, only a minority of them were positive
for CD133, while they all showed negative for CD34. Spe-
cifically, CD49f-positive cells were 91.67 ± 2.31%, 98.77 ±
3.47%, 92.33 ± 8.39%, and 96.72 ± 4.09% (mean ± SD; n =
three independent experiments) for HeLa, SiHa, Ca Ski,
and C-4 I spheroids cells, respectively. CD133-positive
cells were 14.67 ± 4.73%, 9.28 ± 3.15%, 18.36 ± 0.16%,
and 61.45 ± 2.26% (mean ± SD; n = three independent
experiments) for HeLa, SiHa, Ca Ski and C-4 I cells in
spheroids. It has been previously shown that sphere-
forming cells isolated from primary carcinoma of the cer-
vix uteri [15] and samples from human endometrium
[23-25] are negative for CD34. Immunoanalysis of cells
growing under adherent or differentiating conditions by
flow cytometry demonstrated low frequency levels of
these markers, <2% in all cases except for CD49f in SiHa
(13.68 ± 2.79%, mean ± SD; n = three independent
experiments) (Figure 2). These results suggest that
sphere-forming CCICs, under stem cell-selective condi-
tions, are enriched for CD49f compared with cervical cell
lines and CCICs under differentiating conditions.
Cervical cancer cell lines harbor Hoechst effluxing cells
Many stem cells are endowed with the ability to efflux
certain lipophilic drugs due to their cell surface expres-
sion of ABC family members of membrane transporter
proteins and are denominated side population (SP) [18].
When we attempted to explore the existence of a SP
within these cancer cell lines, we found that 1.1 ± 0.19%
of HeLa (mean ± SD; n = 3 independent experiments)
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Page 5 of 14Figure 1 Spheroids of self-renewing cells from established human cell lines of squamous carcinomas and adenocarcinomas of the
cervix. A, Morphology of cells cultured in anchorage-independent conditions as non-adherent clusters one week after plating HeLa (a), SiHa (b),
Ca Ski (c), and C-4 I (d) cells. Magnification is 10X, size bar = 100 μm. B, Serial photographs during culture demonstrated progressive increase
diameter at 4 (a), 8 (b), 12 (c) and 16 days (d). Magnification is 10X, size bar = 100 μm. C, Sphere-forming efficiency (SFE) of spheroid cells on
serial passage from first to fifth generation (G1-G5). Cells were plated at a density of 100 cells/well in 200-μl of serum-free medium (SFM),
spheres were counted weekly. Bar graph represents the SFE mean calculated by counting the number of spheres formed in a given well and
dividing by the total number of cells seeded in the well, represented as a percentage. Error bars represent standard deviation (SD) (n = 3); * p <
0.05 and ** p < 0.005
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Page 6 of 14Figure 2 Immune phenotype analysis of cervical tumor sphere-forming cells. Sphere-forming cells and monolayer cells were stained with
CD34, CD49f, and CD133 conjugated primary antibodies and subjected to flow cytometry. Red line corresponds to sphere-forming cells, green
line to monolayer cells, and black line to isotype control
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notype (Figure 3), confirming that established cell lines
from the uterine cervix contain at least two phenotypi-
cally distinct sub-populations, one of which bears stem-
cell features.
Sphere-forming cells are more tumorigenic than those
grown as monolayer
To investigate the ability of different cell populations to
generate tumors, we examined the efficiency of mono-
layer, sphere-forming, SP, CD34, CD133, and CD49f
cells to form tumors in athymic mice, as previously
shown for other epithelial CICs [9-12]. SP-positive HeLa
cells formed one tumor per two injections with 1 × 10
4
cells and CD34 and CD133 positive cells remained non-
tumorigenic in both cell lines. Injection of 1 × 10
3
CD49f
+ cells were tumorigenic in 1/6 and 2/6 nude
mice, in HeLa and SiHa, respectively. Injections of 1 ×
10
3 HeLa and SiHa spheroid-derived cells were slightly
more tumorigenic in athymic nude mice than CD49f
positive cells. 1 × 10
4 Ca Ski and C-4 I dissociated
spheroid cells allowed formation of tumors, whereas
injection of 1 × 10
6 cells growth as monolayer remained
nontumorigenic (Table 1). HeLa and SiHa cells under
adherent conditions were able to produce tumors when
at least 5 × 10
5 cells were injected, but failed to do so
with Ca Ski and C-4 I, albeit with extended latency (10
weeks). Tumors generated with cells from spheroids
showed a progressive increase in weight in parallel with
the number of injected cells (data not shown). All
tumors were readily apparent by visual inspection and
palpation, except for a tumor formed with 1 × 10
4 SP
+
cells, which was detected only upon necropsy. Tumors
obtained with cell from spheroids were categorized as
poorly differentiated carcinomas (grade 1/grade 2), with
histologic features similar to those of the corresponding
tumors generated with cell grown as monolayers,
including expression of human cytokeratin AE1/3. One
essential criterion for CICs is their ability to propagate
tumors serially in consecutively engrafted animals.
Figure 3 A side population (SP) is present in HeLa and SiHa cell lines. Flow cytometry trace from cervical cell preparation incubated for 90
min at 37°C with Hoechst dye as previously described by Goodell et al. (1996). Delimited red region is the (SP) fraction with and without
Verapamil
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obtained with cells derived from spheroids were per-
formed by s.c. transplantation of 1-mm tumor pieces
into nude mice. Generally, tumors developed 4 weeks
after transplantation with a total of four such successful
serial transplantations. Secondly, dissociated cells from
HeLa tumors obtained with spheroids could reform
spheroids under stem cell-selective conditions. Reinjec-
tion (s.c.) of 1 × 10
4 cells from such secondary sphere-
forming cells resulted in tumors with latency that was
slightly shorter than that of the parental sphere-forming
cells. These results indicate that sphere-forming cells are
more malignant than their parental tumor cells, demon-
strating that a highly tumorigenic subpopulation of cells
resides within cervical cell lines.
Spheroid-derived cells exhibit up-regulated expression of
CICs genes
After demonstration of the ability of tumor-derived cells
to organize self-renewing spheroids that possess higher
tumorigenic capacity, CICs-specific gene expression was
examined. RNA from spheroid or monolayer cells was
analyzed by profiling expression with a cDNA microar-
ray. As a result, analysis showed that 767 and 547 genes
exhibit a >1.5-fold different expression between HeLa
and SiHa cells grown as spheroids versus monolayers,
respectively. Stem-cell markers of adult female repro-
ductive system that were up-regulated in cervical spher-
oids included CD44 [15,23,26-28], ITGB1 (CD29)
[23,24], PSCA [29], NT5E (CD73) [23-25], ENG (CD105)
[23,25], MYC (c-Myc) [15], PCGF4 (BMI-1) [28,30], and
ABCG2 [28,31-33]. Other epithelial CICs markers found
included ITGB6 [34], ALCAM (CD166) [10,35], MET (c-
Met) [36], and KRT15 [ 3 7 ]( F i g u r e4 a ) .W ew e r eh i g h l y
interested and indeed found changes in expression of
members of other gene groups such as epithelial to
mesenchymal transition (EMT)-associated genes (SER-
P I N E 1 ,Y B X 1 ,S M A D 3 ,A C T C 1 ,S M A D 2 ,C T N N B 1 ,
CDH1, TJP1, DSP, VIM, ITGA5, ITGAV,a n dLEF1,F i g -
ure 4b); DNA repair double-strand breaks (DSBs) genes
(XRCC6, XRCC5, XRCC4, and XRCC2, non-homologous
end-joining genes (NHEJ), and RAD51, RAD51L3,
RBBP8, RAD21, RAD54B,a n dSHFM1, homologous
recombination genes (HR), Figures 5a and 5b) and
genes involved in reactive oxygen species (ROS), meta-
bolism (C Y B A ,P R D X 3 ,P R D X 4 ,P R N P ,a n dSOD2,F i g -
ure 5c). Additional files show description of genes in
more detail (Additional files 2,3,4,5,6,&7: Tables S1-S6
and Additional file 8: Figure S2, available online).
CCICs-enriched spheroids possess a higher degree of
radioresistance than monolayer culture-derived cells
To examine whether self-renewing cells from spheroids
(exhibiting higher expression of DNA repair and ROS
metabolism genes) possess a radioresistant phenotype,
we assessed the sensitivity of cervical cell lines to
increasing x-ray treatment (up to 10 Gy) under stem
cell-selective vs. differentiating conditions. As expected,
cervospheres and monolayer cells showed a progressive
decrease in survival with an increasing dose of radiation.
As shown in Figure 5d, after IR treatment, the SF of the
CCICs-enriched population was significantly higher than
that of cells grown as monolayer (HeLa monolayer-
derived cells, mean SF at 2 Gy (SF2Gy)=0 . 4 2±0 . 0 6v s .
spheroid cells SF2Gy = 0.60 ± 0.11, p = 0.05; SiHa mono-
layer-derived cells, SF2Gy = 0.56 ± 0.10 vs. spheroid cells
SF2Gy = 0.65 ± 0.09, p < 0.001; Ca Ski monolayer-
derived cells, SF2Gy = 0.59 ± 0.04 vs. spheroid cells
SF2Gy =0 . 7 6±0 . 0 6 ,p = 0.02; C-4 I monolayer-derived
cells, SF2Gy = 0.39 ± 0.05 vs. spheroid cells SF2Gy =0 . 5 3
± 0.02, p = 0.02; n =3 ,t w o - s i d e dS t u d e n tt test (Table
2). These results support a role for these CICs in cervi-
cal cancer radioresistance.
Discussion
In this report we describe the isolation and characteriza-
tion of a highly tumorigenic subpopulation of cells from
cultures of HeLa, SiHa, Ca Ski, and C-4 I cells that exhi-
bits characteristics of CICs. Previous characterization of
CICs from cervical tumor-derived cultures encompass-
ing stem-like cells capable of self-renewal and extensive
proliferation was described by Feng et al. [15]. To our
knowledge, this is the first characterization of such cells
from some of the best-know human cancer cell lines
derived from uterine cervix tumors. According to the
five separate criteria that have been established to iden-
tify candidate CICs [3,13], we found a subpopulation
restricted to a small minority of the total cells with self-
renewing capacity in vitro and in vivo (criteria a and b).
This subpopulation of sphere-forming cells was more
tumorigenic than unselected parental tumor cells and
resulted in graft tumors that were histologically identical
Table 1 In vivo tumorigenicity of cervical cancer-
iniciating cells
Subpopulation Cells Tumors/injections
HeLa SiHa Ca Ski C-4 I
1×1 0
3 2/6 3/6 0/6 0/6
Spheroid cells 1 × 10
4 4/6 4/6 3/6 2/6
1×1 0
5 5/6 4/6 4/6 4/6
1×1 0
5 0/6 0/6 0/6 0/6
5×1 0
5 1/6 1/6 0/6 0/6
1×1 0
6 5/6 2/6 0/6 0/6
Tumor formation ability of spheroids. Cells were grown in serum-free medium
(SFM) as nonadherent cervospheres and assayed for the ability to form
tumors after s.c. injection on nu-nu mice at 1 × 10
3,1×1 0
4, and 1 × 10
5 cells
per injection. At the same time, adherent cells were assayed at 1 × 10
5,5×
10
5, and 1 × 10
6 cells per injection. The number of tumors that formed and
the number of injections performed are indicated for each condition
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Page 9 of 14to the tumors generated from cell lines without selec-
tion (criterion c). Differentiation into nontumorigenic
cells was evidenced by H&E and cytokeratin staining
(criterion d), and cultured spheroid cells exhibited a dis-
tinctive cell surface phenotype, CD49f (criterion e).
Interestingly, CD49f (ITGA6), an alpha-6 integrin, has
been postulated as the primary receptor protein in nat-
ural human papillomavirus (HPV) infection [38-40];
thus, we postulate that adult reserve cells with expres-
sion of CD49f could be preferentially targeted by high-
risk HPV types during cervical carcinogenesis.
In addition to CICs markers of the adult female repro-
ductive system, many EMT-associated markers were also
found up-regulated in CCICs-enriched spheroids. Recently,
it has been reported that induction of EMT in differen-
tiated immortalized human mammary epithelial cells led to
the acquisition of the CD44
+/CD24
- stem-cell phenotype
[41]. In HeLa, tumorsphere formation and expression of
CD44 were significantly elevated when Twist, a key tran-
scriptional factor of EMT, was overexpressed [42]. Our
spheroid cells also gained expression of human ACTC1
(aSMA) and VIM (Vimentin) mesenchymal markers, simi-
lar to ovarian cancer cell-formed spheroids [43], and dox-
orubicin-selected MCF-7/ADR cells [44] indicating that an
EMT had occurred during cancer progression of the CICs
[45].
Other characteristic of CICs in solid tumors is their
radiation resistance, evidenced in breast cancer [46] and
glioma tumors [47]. Our functional assay showed that
sphere-forming CCICs possess a higher degree of resis-
tance to IR than monolayer cells. We observed increased
clonogenic survival for human CCICs-enriched popula-
tion in which the HR and NHEJ repair pathways and
some growth arrest and DNA damage-inducible genes,
such as GADD45A and PPP1R15A, were hyperstimulated,
similar to the reported expression of DNA repair-DSBs
genes in human embryonic stem cells [48]. Furthermore,
Diehn et al. [49], found that expression of genes involved
in ROS metabolism, such as CYBA, SOD2,a n dPRNP,
was highly overrepresented in breast CICs-enriched
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Figure 4 Cervical cancer-initiating cells (CICs) differentially express characteristic genes of CICs and epithelial to mesenchymal
transition (EMT). A, Expression of CICs markers in HeLa and SiHa spheroid cells. B, Expression of EMT markers in HeLa and SiHa spheroid cells.
Bar graph represents mean fold change (FC) values in spheroid cells compared with those in monolayer, data shown are representative of two
independent experiments
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Page 10 of 14population. These important antioxidant genes were also
enriched in our spheroid cells. Taken together, these
findings are consistent with the hypothesis that enhanced
expression of ROS defenses and up-regulation of EMT-
associated genes [50] in CICs contributes to enhanced
cell survival and acquisition of radioresistance.
Conclusions
We have enriched and characterized a self-renewing
subpopulation of CICs among four well known human
cancer-derived cell lines (HeLa, SiHa, Ca Ski, and C-4
I), established from squamous carcinomas and adeno-
carcinomas of the uterine cervix. CICs were enriched as
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Figure 5 Cervical cancer-initiating cells (CCICs) are more resistant to X-ray treatment. A, DNA repair double-strand breaks (DSB) genes
differentially expressed in HeLa CCICs. B, as in A but SiHa CICs. C, Reactive oxygen species (ROS) metabolism genes overrepresented in HeLa and
SiHa CCICs-enriched spheroids compared with monolayer counterparts. D, Cell survival curves for CCICs-enriched spheroid and monolayer cells.
For x-ray treatment, cells were dissociated and irradiated in suspension with 0, 2, 4, 6, 8, and 10 Gy with a linear accelerator Clinac 2100C
operating at 200 cGy/min and 6MV. Cells were then seeded in six-well dishes at an appropriate number with DMEM and noble agar (0.3%) for
clonogenic survival assay. Twenty one days after irradiation colonies were fixed and stained. Colonies comprising >50 cells were counted for
each dose point. To determine surviving fractions (SFs) counts were normalized using the plating efficiency (PE) of the unirradiated
corresponding control. Error bars represent standard deviation (SD). Data shown are representative of three independent experiments; S: CCICs-
enriched spheroid cells
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Page 11 of 14spheroids in selective medium with defined factors and
found capable of generation of reproducible tumor phe-
notypes in nu-nu mice and serial propagation. Injection
o f1×1 0
3 dissociated spheroid cells allowed formation
of tumors in the majority of animals, whereas injection
of 1 × 10
5 monolayer cells remained nontumorigenic for
all cell lines. Sphere-forming CICs expressed CD49f sur-
face marker. When gene profiling analysis of HeLa and
SiHa was performed, up-regulation of CICs markers
characteristic of the female reproductive system and
EMT transition-associated markers was observed. More
importantly, this analysis indicated that radioresistance
genes were also up-regulated, including components of
the DSB-DNA repair machinery and the metabolism of
ROS. CICs-enriched populations indeed exhibited an
increased resistance to IR. This could be important for
addressing and understanding the possible implication
of CICs in cancer treatment.
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Table 2 SF2, a and b values in spheres and their monolayer counterparts from established cervical cell lines
a (Gy
-1) b (Gy
-2)S F 2
Cell line Monolayer Sphere Monolayer Sphere Monolayer Sphere
HeLa 0.166 ± 0.044 0.082 ±0.017 0.011 ± 0.006 0.013 ± 0.007 0.42 ± 0.06 0.60 ± 0.11
SiHa 0.099 ± 0.021 0.070 ± 0.011 0.013 ± 0.004 0.016 ± 0.005 0.56 ± 0.10 0.65 ± 0.09
Ca Ski 0.087 ± 0.032 0.032 ± 0.007 0.012 ± 0.000 0.013 ± 0.008 0.59 ± 0.04 0.76 ± 0.06
C-4 I 0.151 ± 0.075 0.115 ± 0.029 0.009 ± 0.003 0.011 ± 0.005 0.39 ± 0.05 0.53 ± 0.02
Parameters of cell survival curves were calculated using a linear-quadratic model for surviving fraction, SF. = exp (-ad-bd
2). a: number of logs of cells killed per
gray from the linear portion of the survival curve; b: number of logs of cells killed per gray
2 from the quadratic component. Three independent experiments
were performed.
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